Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, The Netherlands.
Department of Interventional Radiology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, The Netherlands.
HPB (Oxford). 2019 Jul;21(7):865-875. doi: 10.1016/j.hpb.2018.10.020. Epub 2018 Dec 31.
Over the years, high-volume pancreatic centers expanded their indications for pancreatoduodenectomy (PD) but with unknown impact on surgical and oncological outcome.
All consecutive PDs performed between 1992-2017 in a single pancreatic center were identified from a prospectively maintained database and analyzed according to three time periods.
In total, 1434 patients underwent PD. Over time, more elderly patients underwent PD (P < 0.001) with increased use of vascular resection (10.4 to 16.0%, P < 0.001). In patients with cancer (n = 1049, 74.8%), the proportion pT3/T4 tumors increased from 54.3% to 70.6% over time (P < 0.001). The postoperative pancreatic fistula (16.0%), postpancreatectomy hemorrhage (8.0%) and delayed gastric emptying (31.0%) rate did not reduce over time, whereas median length of stay decreased from 16 to 12 days (P < 0.001). The overall failure-to-rescue rate (6.9%) and in-hospital mortality (2.2%) remained stable (P = 0.89 and P = 0.45). In 523 patients with pancreatic cancer (36.5%), the use of both adjuvant and neoadjuvant chemotherapy increased over time (both p<0.001), and the five-year overall survival improved from 11.0% to 17.4% (P < 0.001).
In a period where indications for PD expanded, with more elderly patients, more advanced cancers and increased use of vascular resections, surgical outcome remained favorable and five-year survival for pancreatic cancer improved.
多年来,大容量胰腺中心扩大了胰十二指肠切除术(PD)的适应证,但对手术和肿瘤学结果的影响尚不清楚。
从一个前瞻性维护的数据库中确定了 1992 年至 2017 年间在一个单一的胰腺中心进行的所有连续 PD,并根据三个时期进行分析。
共有 1434 例患者接受了 PD。随着时间的推移,更多的老年患者接受了 PD(P < 0.001),血管切除的使用率也有所增加(10.4%至 16.0%,P < 0.001)。在癌症患者(n = 1049,74.8%)中,随着时间的推移,pT3/T4 肿瘤的比例从 54.3%增加到 70.6%(P < 0.001)。术后胰瘘(16.0%)、胰切除术后出血(8.0%)和延迟胃排空(31.0%)的发生率并未随时间降低,而中位住院时间从 16 天缩短至 12 天(P < 0.001)。整体抢救失败率(6.9%)和院内死亡率(2.2%)保持稳定(P = 0.89 和 P = 0.45)。在 523 例胰腺癌患者(36.5%)中,辅助和新辅助化疗的应用均随时间增加(均 P<0.001),五年总生存率从 11.0%提高到 17.4%(P < 0.001)。
在 PD 适应证扩大、老年患者增加、癌症更晚期和血管切除术使用率增加的时期,手术结果仍然有利,胰腺癌的五年生存率提高。